OnKure Therapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
OKUR on Nasdaq
Industry
Pharmaceutical Preparations
Location
6707 Winchester Circle, Suite 400, Boulder, CO

Insiders trading volume in the past year

OnKure Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novo Holdings A/S 10%+ Owner $20.9M Jun 23, 2023
Niall O'Donnell Director $13.7M Jun 6, 2023
Acorn Bioventures, L.P. 10%+ Owner $9.1M +$2.59M +39.8% May 15, 2025
Acorn Bioventures 2, L.P. 10%+ Owner $2.87M May 15, 2025
Gregory J. Flesher President and CEO, Director $723K Dec 9, 2022
Braden Michael Leonard Former 10% owner of RPHM $670K Oct 7, 2024
Michael Cruse Chief Operating Officer $310K Dec 9, 2022
Ashley Hall Chief Development Officer $249K Aug 28, 2023
Vineet R. Jindal Chief Financial Officer $230K Dec 10, 2021
Alejandro Dorenbaum Chief Medical Officer $188K Dec 9, 2022
Jennifer Lam VP of Finance & Administration $129K Dec 9, 2022
Isaac Manke Director $40.3K Sep 30, 2025
Jason A. Leverone Chief Financial Officer $33.1K -$10.7K -24.4% Sep 22, 2025
Edward T. Mathers Director $30K Sep 30, 2025
R. Michael Carruthers Director $13.2K May 28, 2025
Nicholas A. Saccomano President and CEO, Director $9.2K -$3.01K -24.7% Sep 22, 2025
Cormorant Asset Management, LP Former 10% Owner $0 -$3.41M -100% May 15, 2025
Michael G. Grey Director May 28, 2025
Andrew John Phillips Director May 28, 2025
Valerie Malyvanh Jansen Director May 28, 2025
Dylan Hartley Chief Scientific Officer Jan 27, 2025
Samuel Agresta Chief Medical Officer Jan 27, 2025
Bali Muralidhar Director Jun 6, 2023
Paul W. Hoelscher Director Jun 6, 2023
Eric M. Dube Director Jun 6, 2023
Kenneth Ph.D. Harrison Director Apr 8, 2021
Stacey Denenberg Seltzer Director Jun 6, 2023
Roshawn Blunt Director Jun 6, 2023
Wendy S. Johnson Chief Development Officer Jul 14, 2021

Recent Insider Transactions by Companies or Individuals for OnKure Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.